Abstract A collection of 20 multidrug-resistant Providencia stuartii isolates recovered from 2005 to 2009 at the Military Hospital of Tunis, Tunisia, was analysed. They all expressed the extended-spectrum β-lactamase (ESBL) VEB-1a. The bla VEB-1a gene was plasmid-located and it was associated with complex genetic structures, including Re elements. Pulsed-field gel electrophoresis (PFGE) revealed a clonal relationship between all of these isolates. This study identified a nosocomial dissemination of an ESBL-producing P. stuartii clone in a Tunisian hospital over a long period of time.
Providencia stuartii is an opportunistic pathogen that has rarely been involved in nosocomial outbreaks [1] . Resistance to expanded-spectrum cephalosporins in that species results mostly from the overexpression of its natural AmpC, but also from the acquisition of extended-spectrum β-lactamases (ESBLs) of the TEM-, SHV-or CTX-M-types [2] [3] [4] . In addition, the Ambler class A ESBL VEB-1 has been identified in P. stuartii [5, 6] . The bla VEB-1 gene had been initially identified in an Escherichia coli isolate from a Vietnamese patient [7] . Then, it was identified worldwide, and in many Gram-negative rods, such as Pseudomonas aeruginosa, Acinetobacter baumannii and several Enterobacteriaceae [8, 9] . Unlike most of the ESBL-encoding genes, bla VEB-1 is usually part of a gene cassette itself located in class 1 integrons [10] .
The aim of the present study was to investigate the mechanisms of β-lactam resistance of multidrug-resistant P. stuartii isolates recovered during a 4-year period in a hospital in Tunis, Tunisia, from severely ill patients.
Twenty multidrug-resistant P. stuartii clinical isolates were collected between 2005 and 2009 from 20 patients who had been hospitalised in the intensive care unit at the Military Hospital of Tunis. These isolates were most frequently recovered from blood cultures (13 isolates), but also from tracheal aspirations (four isolates), pus (two isolates), chest drainage (one isolate) and rectal swabs (three isolates) ( Table 1 ). They were identified using the VITEK 2 system (bioMérieux, La Balme-les-Grottes, France) and the API 20E system (bioMérieux). ESBL detection was performed as described by the double disk diffusion test and revealed synergies between amoxicillin-clavulanic acid and oxyiminocephalosporins (cefotaxime, ceftazidime) containing disks for all isolates. In addition, an unusual synergy image between cefoxitin and ceftazidime was observed for 15 isolates which were retained for further analysis (Table 1) . Minimum inhibitory concentrations (MICs) were determined by a microdilution method according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) [11] and gave identical results for these 15 isolates, with a significant decrease of the MIC of ceftazidime in the presence of clavulanic acid, confirming the production of an ESBL (Table 2) .
In order to investigate the molecular basis of the β-lactam resistance observed in these strains, and since the synergy between cefoxitin and ceftazidime had been already observed for VEB-1-producing enterobacterial isolates [7] , polymerase chain reaction (PCR) analysis was performed with specific VEB-F and VEB-B internal primers for the detection of the bla VEB-1 gene, followed by a PCR using VEBcas-F and VEBcas-B external primers to amplify the entire veb-1 gene cassette [9] . DNA sequencing of these PCR products and deduced amino acid sequence analysis revealed that the 15 isolates produced the same ESBL VEB-1a [12] . PCR amplification experiments failed using primers located in the bla VEB-1a gene and in the class 1 integron conserved sequences (5′-CS and 3′-CS [13] ), thus, suggesting that bla VEB-1a was not part of a class 1 integron structure. However, PCR mapping performed as described [7] revealed that bla VEB-1a was associated to two Re1 repeated elements, as previously identified in P. aeruginosa 10.2 from India [14] .
To characterise the genetic support of the bla VEB-1a gene, plasmid DNA was extracted by the Kieser technique [15] and transformed into E. coli DH10B recipient strain by electroporation [14] , resulting in the transfer of the ESBL phenotype after selection made with ceftazidime. Transfer by conjugation performed as previously described [7] failed, suggesting that the plasmid harbouring the bla VEB-1a gene was not self-conjugative.
Genotypic comparison was performed by pulsed-field gel electrophoresis (PFGE) as previously described [16] , using the SmaI restriction enzyme. PFGE analysis revealed an identical pattern for all VEB-1a-positive isolates (data not shown), indicating the spread and persistence of a single P. stuartii clone within the hospital over that 4-year period.
This study constitutes the first report of a hospital outbreak due to a VEB-1a-producing P. stuartii. This bla VEB-1a gene was found to be plasmid-located and associated to a complex structure involving Re elements, as previously found in P. aeruginosa [14] . This is a further example of an association between these Re elements and the acquisition of a bla VEB-1 -like gene. Noteworthy, a bla VEB-1b -positive P. stuartii isolate (VEB-1a and VEB-1b differing by one amino acid substitution in their respective leader peptide sequences) had been previously identified in Algeria, being also associated with Re sequences [6] . We show here that a multidrug-resistant and ESBL-producing P. stuartii clone has been responsible for nosocomial infections over a long period of time. Infection control policies and further monitoring should be implemented in order to better control the dissemination of that clone. 
